Internal Medicine Research & Non Research Awards
From 04/01/2016- To 06/30/2016
PI Proposal Title ID# Sponsor Dates Direct Cost Indirect Cost Total Cost
Zolty, Ronald, Efficacy and safety of finerenone in subjects with chronic heart failure at high risk of recurrent heart failure decompensation (FINESSE Study), 19577, Bayer Healthcare Pharmaceuticals, 02/19/16-02/18/17, $4,563, $1,186, $5,749
Zolty, Ronald, A Double-blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients with Left Ventricular Systopic Dysfunction Undergoing Cardiiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS), 19551, Tenax Therapeutics, Inc., 04/13/16-04/12/17, $66,131, $16,284, $82,415
Zolty, Ronald, A prospective, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of macitentan in patients with pulmonary hypertension after left ventricular assist device implantation (SOPRANO Study), 19510, Actelion Pharmaceuticals Ltd., 05/12/16-05/11/18, $36,541, $8,851, $45,392
Boerner, Brian Paul, Natural History Study of the Development of Type 1 Diabetes, 10951, University of South Florida, 07/01/14-06/30/15, $2,854, $8,567, $11,421
Desouza, Cyrus Victor, Emotional Distress in a Comparative Effectiveness Trial of Diabetes Treatments (EDS), 18282, George Washington University, 09/01/15-03/31/16, $5,845, $2,952, $8,797
Desouza, Cyrus Victor, Midwestern Collaborative for Treating Obesity in Rural Primary Care, 18181, University of Kansas Medical Center Research Institute Inc., 09/01/15-12/31/15, $1,183, $473, $1,656
Desouza, Cyrus Victor, Midwestern Collaborative for Treating Obesity in Rural Primary Care, 18181, University of Kansas Medical Center Research Institute Inc. 01/01/16-12/31/16, $153,930, $61,572, $215,502
Desouza, Cyrus Victor, Vitamin D to prevent type 2 diabetes (D2d study), 15982, Tufts University, 06/01/16-05/31/17, $188,838, $86,342, $275,180
Desouza, Cyrus Victor, NERBA ICA for Curtis Perriotte-Olson, 18695, Nebraska Educational Biomedical Research Association, 06/01/16-06/30/17, $11,453, $0, $11,453
Desouza, Cyrus Victor, A Trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes (PIONEER), 19796, Novo Nordisk Pharmaceuticals, Inc., 06/27/16-06/26/18, $179,214, $46,336, $225,550
Ouellette, Michel M, RAC1 GTPase in tumorigenesis and progression of pancreatic cancer, 19286, DHHS/NIH/NCI, 05/01/16-04/30/17, $249,000, $125,745, $374,745
Rasineni, Karuna, Pancreas-Adipose-Liver Axis: Role of Ghrelin and Insulin in Alcoholic Fatty Liver, 19221, DHHS/NIH/NIAAA, 05/05/16-04/30/17, $100,705, $8,056, $108,761,
Florescu, Diana Florentina, Clostridium difficile colitis in pediatric small bowel transplant recipients: epidemiology, risk factors and outcome, 19555, Merck Sharp & Dohme Corp. 12/22/15-12/21/16, $14,903, $4,375, $19,278
Florescu, Diana Florentina, An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease, 19640, Chimerix, Inc., 03/22/16-02/28/17, $5,000, $0, $5,000
Florescu, Diana Florentina, Adenovirus Infection in Solid Organ Transplant Recipients, 19658, Chimerix, Inc., 03/13/16-03/12/17, $23,163, $5,892, $29,055
Florescu, Diana Florentina, A Prospective Observational Trial to Evaluate the Correlation of T-SPOT Response to CMV Infection and T cell-mediated Acute Graft Rejection: The PROTECT Study, 19747, Oxford Immunotec, Inc., 05/16/16-05/15/18, $47,619, $12,381, $60,000,
Swindells, Susan, AIDS Drug Assistance Program [ADAP] Ryan White Title II Program (Part B), 1285, NE DHHS, 09/01/15-09/29/16, $270,834, $0, $270,834
Swindells, Susan, AIDS Clinical Trials Group Network (ACTG), 16481, Brigham & Women’s Hospital, 12/01/15-11/30/16, $50,400, $25,452, $75,852
Swindells, Susan, AIDS Clinical Trials Group (ACTG): Protocol Chair Support, 20097, Brigham & Women’s Hospital, 12/01/15-11/30/16, $12,500, $6,313, $18,813
Swindells, Susan, AIDS Drug Assistance Program [ADAP] Ryan White Title II Program (Part B), 1285, NE DHHS, 04/01/16-03/31/17, $3,110,644, $0, $3,110,644
Zimmer, Andrea Joan, MSG-13: A Multi-center, Case Control Study of a Lateral Flow Assay and Enzyme Immunoassay for Diagnosis of Histoplasmosis, 19771, University of Alabama – Birmingham, 06/02/16-06/01/17, $6,600, $1,320, $7,920
Bhatt, Vijaya R, A Randomized, Parallel-Cohort Phase 1 Study of INCB039110 in Combination With Corticosteroids for the Treatment of Grades II to IV Acute Graft-Versus-Host Disease,19279, Incyte Corporation, 03/28/16-07/31/17, $250,694, $64,530, $315,224
Ganti, Apar K, A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy vs. Standard of Care Platinum-based Chemotherapy in First-Line Treatment of Patients with Advanced. (MYSTIC Study), 19288, AstraZeneca LP, 04/12/16-04/11/18, $106,206, $26,964, $133,170
Vose, Julie M, Phase I/II Study of Lenalidomide Maintenance Following BEAM (Rituximab) for Chemo-Resistant or High Risk Non-Hodgkin’s Lymphoma, 12580, Celgene Corporation, 08/01/15-07/31/19, $190,476, $49,524, $240,000
Vose, Julie M, EBV Auto-HCT Study, 19363, Columbia University (NY), 09/15/15-06/30/16, $5,079, $1,321, $6,400
Dickinson, John David, Role of Autophagy and the ATG16L1 Gene Variant in Cystic Fibrosis,19528, Cystic Fibrosis Foundation, 04/01/16-03/31/17, $49,093, $3,927, $53,020
Grant, Kathleen, Understanding veterans’ preferences for smoking cessation treatment in primary care, 20272, U.S. Veterans Administration, 06/01/2016-05/31/2017, $10,600, 0, $10,600.
Gries, Tara Marie, The role of omega-3 fatty acids and bioactive lipid signaling in airway inflammation and resolution following organic dust exposures, 18609, DHHS/NIH/NIEHS, 07/01/16-06/30/17, $83,091, $6,647, $89,738
Harrington, John J, Tailored treatment to enhance risk perception in sleep apnea – subcontract with National Jewish Health, 18868, National Jewish Research, 04/01/16-03/31/17, $14,614, $7,381, $21,995
Wyatt, Todd A, Mechanism of decreased lung secretory IgA in cigarette smokers who drink alcohol, 19830, NE DHHS – LB506,07/01/16-06/30/17, $50,000, $0, $50,000
O’Dell, James Robert, ACE Protocol ARA08: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA), 20034, University of California – San Francisco, 12/01/15-11/30/16, $82,005, $40,151, $122,156
Thiele, Geoffrey Milton, Alcohol Induces Muscle Autophagy by a Novel AMPK Independent PI3K Mediated Mechanism, 17144, Cleveland Clinic Foundation, 09/25/15-08/31/16, $11,375, $5,744, $17,119